🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07690462
Starting soon Observational

Infrared Fluorescence Staining Versus Frozen Section for Prostate Cancer Surgery

NCT07690462 · tracked via the Priya Life Science China tracker
Sponsor
Xiangya Hospital of Central South University
Phase
Observational
Started
2026-07
Last updated
2026-07-08

Condition(s) studied

Prostate Cancer

Study summary

This study aims to validate the accuracy of the infrared fluorescence rapid detection technique for the diagnosis of prostate biopsy specimens, and to compare it with intraoperative frozen section and conventional paraffin section (the gold standard), so as to evaluate its feasibility and value in clinical application.

Eligibility

Sex
MALE
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. All adult male patients who are scheduled to undergo prostate biopsy at the Department of Urology, Xiangya Hospital due to clinical suspicion (e.g., elevated PSA, abnormal digital rectal examination, or suspicious lesions on imaging). 2. Patients whose cardiac, pulmonary, hepatic, renal, and coagulation functions are essentially normal and who are able to tolerate the biopsy procedure. 3. The patient or their legally authorized representative has signed the written informed consent form. Exclusion Criteria: 1. Patients in the acute infection phase or febrile period. 2. Patients with severe bleeding tendency conditions who are unable to undergo biopsy. 3. Patients with any serious concomitant disease that, in the investigator's opinion, may interfere with the study results or increase the patient's risk (e.g., hypertensive crisis; decompensated cardiac insufficiency; severe internal or external hemorrhoids, perianal or rectal lesions, etc.).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Xiangya Hospital Central South University Changsha Hunan

More Xiangya Hospital of Central South University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07690462 on ClinicalTrials.gov ↗ ← All trials in China